18 May 2020
The Canadian Center for Vaccinology (CCfV) at Dalhousie University has received approval from Health Canada to conduct the country’s first clinical trials of a potential Covid-19 vaccine, which has been developed by Chinese company CanSino Biologics. The trials are expected to be commenced in the coming two weeks following ethics board approval.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The UK Government will provide £84m in funding and manufacturing support for the University of Oxford and Imperial College London researchers working on Covid-19 vaccine programme. Also, Oxford University signed global licensing deal with AstraZeneca, which agreed to produce up to 30 million vaccine doses by September.
Sorrento Therapeutics has reported that its Covid-19 antibody candidate, STI-1499, was able to completely block the virus infection during in-vitro preclinical studies. The company intends to develop an antibody cocktail that would protect from Covid-19.
Cigarette company British American Tobacco (BAT) is ready to study in human clinical trials of its Covid-19 vaccine candidate made using proteins from tobacco leaves, according to Reuters. The vaccine candidate is said to have shown positive immune response in pre-clinical studies. On 15 May, the company filed a pre-investigative new drug application with the US Food and Drug Administration (FDA), which acknowledged the submission.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
